Tao Zhou

发表

Prognostic significance of miR-126 in various cancers: a meta-analysis

Baosheng Li, Zi-cheng Zhang, H. Guan, 2016, OncoTargets and therapy.

Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma.

Baosheng Li, Hong-sheng Li, Zhong-tang Wang, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up

Baosheng Li, Zhong-tang Wang, Hong-fu Sun, 2017, Oncotarget.

Low-density lipoprotein promotes lymphatic metastasis of esophageal squamous cell carcinoma and is an adverse prognostic factor

Yong Yin, Chengxin Liu, T. Zhou, 2018, Oncology letters.

The early predictive value of a decrease of metabolic tumor volume in repeated (18)F-FDG PET/CT for recurrence of locally advanced non-small cell lung cancer with concurrent radiochemotherapy.

Baosheng Li, Z. Fu, Wei Huang, 2015, European journal of radiology.

Study Of Local Three-Dimensional Conformal Radiotherapy Combined With Transcatheter Arterial Chemoembolization for Patients With Stage III Hepatocellular Carcinoma

Jinming Yu, Baosheng Li, L. Xing, 2003, American journal of clinical oncology.

Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases.

Baosheng Li, Hong-fu Sun, Wei Huang, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer

Baosheng Li, Li Ma, Wei Huang, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

The error estimate for contouring the brainstem in radiotherapy of head and neck cancer: a multi-center study from north China.

Yong Yin, Baosheng Li, G. Gong, 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Re-irradiation alternatives for recurrent high-grade glioma

Baosheng Li, T. Zhou, Zi-cheng Zhang, 2016, Oncology letters.

High dose radiation therapy based on normal tissue constraints with concurrent chemotherapy achieves promising survival of patients with unresectable stage III non-small cell lung cancer.

Jian Zhang, Baosheng Li, Zhong-tang Wang, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer

Jian Zhang, Baosheng Li, Zhong-tang Wang, 2016, Oncotarget.

Explore the Radiotherapeutic Clinical Target Volume Delineation for Thoracic Esophageal Squamous Cell Carcinoma from the Pattern of Lymphatic Metastases

Jian Zhang, Baosheng Li, Zhong-tang Wang, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial

Wendong Gu, Zhong-tang Wang, Yunwei Han, 2024, Cancer communications.

Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.

Jian Zhang, Baosheng Li, Wei Huang, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Response Prediction Using 18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy

J. Duan, Ning Liu, T. Zhou, 2022, The Journal of Nuclear Medicine.